BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,047 filers reported holding BAXTER INTL INC in Q4 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $332,000 | -13.5% | 4,279 | -4.4% | 0.02% | -14.3% |
| Q4 2021 | $384,000 | -6.3% | 4,478 | -12.2% | 0.03% | -15.2% |
| Q3 2021 | $410,000 | -8.5% | 5,103 | -8.2% | 0.03% | -10.8% |
| Q2 2021 | $448,000 | -6.1% | 5,561 | -1.7% | 0.04% | -19.6% |
| Q1 2021 | $477,000 | -94.1% | 5,655 | -94.4% | 0.05% | -94.4% |
| Q4 2020 | $8,048,000 | -13.5% | 100,294 | -13.3% | 0.82% | -24.3% |
| Q3 2020 | $9,302,000 | -23.4% | 115,669 | -18.0% | 1.08% | -32.5% |
| Q2 2020 | $12,140,000 | +3.4% | 140,994 | -2.5% | 1.60% | -14.3% |
| Q1 2020 | $11,746,000 | -2.1% | 144,672 | +0.8% | 1.87% | +24.4% |
| Q4 2019 | $12,001,000 | -1.1% | 143,520 | +3.5% | 1.50% | -10.4% |
| Q3 2019 | $12,133,000 | +4.7% | 138,714 | -2.0% | 1.68% | +4.5% |
| Q2 2019 | $11,593,000 | +6.6% | 141,546 | -1.2% | 1.60% | +1.3% |
| Q1 2019 | $10,878,000 | +18.7% | 143,249 | +2.9% | 1.58% | +2.3% |
| Q4 2018 | $9,165,000 | +3294.4% | 139,249 | +3876.3% | 1.55% | +3583.3% |
| Q3 2018 | $270,000 | +4.7% | 3,502 | +0.1% | 0.04% | -2.3% |
| Q2 2018 | $258,000 | – | 3,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |